Media Summary: EFPIA Director General Richard Bergström. In this episode of "In the Interim…", Dr. Scott Berry explores the challenge of protracted endpoint timelines in adaptive Listen to a soundcast of the May 8, 2024, Q&A with FDA: The Role of Artificial Intelligence in
Clinical Behavioural Trial Designs E - Detailed Analysis & Overview
EFPIA Director General Richard Bergström. In this episode of "In the Interim…", Dr. Scott Berry explores the challenge of protracted endpoint timelines in adaptive Listen to a soundcast of the May 8, 2024, Q&A with FDA: The Role of Artificial Intelligence in Learn the essential principles behind rigorous
